A phase II study of fulvestrant in the treatment of multiply-recurrent epithelial ovarian cancer

Gynecologic Oncology ◽

10.1016/j.ygyno.2009.01.012 ◽

2009 ◽

Vol 113 (2) ◽

pp. 205-209 ◽

Author(s):

Peter A. Argenta ◽

Sajeena G. Thomas ◽

Patricia L. Judson ◽

Levi S. Downs ◽

Melissa A. Geller ◽

...

Keyword(s):

Ovarian Cancer ◽

Epithelial Ovarian Cancer ◽

Phase Ii ◽

Download Full-text

Gemcitabine combined with cisplatin as first-line treatment in patients 60 years or older with epithelial ovarian cancer: a phase II study

International Journal of Gynecological Cancer ◽

10.1046/j.1525-1438.2003.13039.x ◽

2003 ◽

Vol 13 (2) ◽

pp. 130-137 ◽

Author(s):

T. Bauknecht ◽

A. Hefti ◽

G. Morack ◽

C. Villena-Heinsen ◽

D. Wallwiener ◽

...

Keyword(s):

Ovarian Cancer ◽

Epithelial Ovarian Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Line Treatment ◽

First Line Treatment

Download Full-text

A phase II study of erlotinib (OSI-774) given in combination with carboplatin in patients with recurrent epithelial ovarian cancer (NCIC CTG IND.149)

Gynecologic Oncology ◽

10.1016/j.ygyno.2010.05.005 ◽

2010 ◽

Vol 118 (3) ◽

pp. 308-312 ◽

Author(s):

H. Hirte ◽

A. Oza ◽

K. Swenerton ◽

S.L. Ellard ◽

R. Grimshaw ◽

...

Keyword(s):

Ovarian Cancer ◽

Epithelial Ovarian Cancer ◽

Phase Ii ◽

Download Full-text

A phase II study of docetaxel weekly in combination with carboplatin every three weeks as first line chemotherapy in stage IIB-IV epithelial ovarian cancer: Neurological toxicity and quality-of-life evaluation

International Journal of Oncology ◽

10.3892/ijo.2011.1286 ◽

2011 ◽

Author(s):

Bengt Sorbe

Keyword(s):

Quality Of Life ◽

Ovarian Cancer ◽

Epithelial Ovarian Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Neurological Toxicity ◽

Life Evaluation ◽

Line Chemotherapy

Download Full-text

Multicenter phase II study of gemcitabine in previously untreated patients with advanced epithelial ovarian cancer

Anti-Cancer Drugs ◽

10.1097/00001813-200109000-00002 ◽

2001 ◽

Vol 12 (8) ◽

pp. 647-652 ◽

Author(s):

C R Underhill ◽

F X Parnis ◽

M S Highley ◽

J Ahern ◽

P G Harper ◽

...

Keyword(s):

Ovarian Cancer ◽

Epithelial Ovarian Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Multicenter Phase ◽

Advanced Epithelial Ovarian Cancer

Download Full-text

Hyperthermic Intraperitoneal Chemotherapy After Extensive Cytoreductive Surgery in Patients with Primary Advanced Epithelial Ovarian Cancer: Interim Analysis of a Phase II Study

Annals of Surgical Oncology ◽

10.1245/s10434-008-0299-y ◽

2009 ◽

Vol 16 (4) ◽

pp. 993-1000 ◽

Author(s):

Myong Cheol Lim ◽

Sokbom Kang ◽

Jaeho Choi ◽

Yong Jung Song ◽

Sohee Park ◽

...

Keyword(s):

Ovarian Cancer ◽

Epithelial Ovarian Cancer ◽

Phase Ii ◽

Intraperitoneal Chemotherapy ◽

Cytoreductive Surgery ◽

Interim Analysis ◽

Hyperthermic Intraperitoneal Chemotherapy ◽

Phase Ii Study ◽

Advanced Epithelial Ovarian Cancer

Download Full-text

A phase II study of single-agent RO4929097, a gamma-secretase inhibitor of Notch signaling, in patients with recurrent platinum-resistant epithelial ovarian cancer: A study of the Princess Margaret, Chicago and California phase II consortia

Gynecologic Oncology ◽

10.1016/j.ygyno.2015.03.005 ◽

2015 ◽

Vol 137 (2) ◽

pp. 216-222 ◽

Author(s):

Ivan Diaz-Padilla ◽

Michelle K. Wilson ◽

Blaise A. Clarke ◽

Hal W. Hirte ◽

Stephen A. Welch ◽

...

Keyword(s):

Ovarian Cancer ◽

Epithelial Ovarian Cancer ◽

Notch Signaling ◽

Phase Ii ◽

Phase Ii Study ◽

Single Agent ◽

Gamma Secretase ◽

Platinum Resistant ◽

Secretase Inhibitor ◽

Gamma Secretase Inhibitor

Download Full-text

Principal results of the cancer of the ovary abiraterone trial (CORAL): A phase II study of abiraterone in patients with recurrent epithelial ovarian cancer (CRUKE/12/052)

Annals of Oncology ◽

10.1093/annonc/mdw435.27 ◽

2016 ◽

Vol 27 ◽

pp. vi569 ◽

Author(s):

S. Banerjee ◽

L. Kilburn ◽

R. Bowen ◽

H. Tovey ◽

M. Hall ◽

...

Keyword(s):

Ovarian Cancer ◽

Epithelial Ovarian Cancer ◽

Phase Ii ◽

Download Full-text

SALVAGE CHEMOTHERAPY WITH DOCETAXEL, OXALIPLATIN AND GEMCITABINE IN PLATINUM-PRETREATED ADVANCED EPITHELIAL OVARIAN CANCER - RESULTS OF A PHASE II STUDY

International Journal of Gynecological Cancer ◽

10.1136/ijgc-00009577-200303001-00047 ◽

2003 ◽

Vol 13 (Suppl 1) ◽

pp. 14.2-14

Author(s):

G. Seliger ◽

L. P. Mueller ◽

T. Buechele ◽

O. Kellner ◽

A. Grothey ◽

...

Keyword(s):

Ovarian Cancer ◽

Epithelial Ovarian Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Salvage Chemotherapy ◽

Advanced Epithelial Ovarian Cancer

Download Full-text

A phase II study of gemcitabine in platinum pre-treated patients with advanced epithelial ovarian cancer

Annals of Oncology ◽

10.1023/a:1008469212268 ◽

1998 ◽

Vol 9 (12) ◽

pp. 1343-1345 ◽

Author(s):

M. Friedlander ◽

M.J. Millward ◽

D. Bell ◽

R. Bugat ◽

P. Harnett ◽

...

Keyword(s):

Ovarian Cancer ◽

Epithelial Ovarian Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Epithelial Ovarian Cancer

Download Full-text

Hyperthermic intraperitoneal chemotherapy following extensive cytoreductive surgery in patients with primary advanced epithelial ovarian cancer: Result of a prospective phase II study

Gynecologic Oncology ◽

10.1016/j.ygyno.2013.04.064 ◽

2013 ◽

Vol 130 (1) ◽

pp. e3-e4

Author(s):

M. Lim ◽

M. Im ◽

H. Yoo ◽

S. Seo ◽

S. Kang ◽

...

Keyword(s):

Ovarian Cancer ◽

Epithelial Ovarian Cancer ◽

Phase Ii ◽

Intraperitoneal Chemotherapy ◽

Cytoreductive Surgery ◽

Hyperthermic Intraperitoneal Chemotherapy ◽

Phase Ii Study ◽

Prospective Phase ◽

Advanced Epithelial Ovarian Cancer

Download Full-text